This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
Working Groups
ESBB Working Groups

ESBB Working Groups are composed of members who join forces in order to identify and tackle important, unresolved issues in the biobanking field. Their goal is to provide strategies for addressing these issues and to develop the tools that will address them.

 
SOCIAL MEDIA WG

Facebook, Instagram, LinkedIn, Twitter and more. The truth is: “Social Media is a platform for real networking, growth and engagement for any venture irrespective of the industry” Scion social. So how is social media important for us and our biobank community? Together, we aim to: increase awareness for biobanking and its potentials and inform, educate, engage and involve patients & public within ESBB focus areas and form strong partnerships for the patient’s benefit

  • Co-Chair & Mentor: Dr. Ayat Salman, McGill University Health Centre, Canada
 

GROUP's ONLINE COMMUNITY

ACADEMIC & INDUSTRY COOPERATION WG

Our aim (formerly ESBB Translate) is to bring together ESBB members and pharma/biotech industry representatives in order to identify, elaborate and promote academic-industry co-operations. We will identify the needs of Industry, what the biobanks can offer and how both Industry and academia can ensure they are ready to work together when the need arises. We focus on appropriate documentation, contract needs, sample & data requirements, and regulatory aspects.

  • Chair: Anna Michalska-Falkowska, Medical University of BialystokPoland
 

GROUP's ONLINE COMMUNITY

REGULATORY, ETHICS & GDPR (ELSI) WG

To provide a voice and exchange on regulatory and ethics issues, including GDPR, and its implications on biobanking and research.

  • Co-Chair: Prof. Christoph Brochhausen-Delius, Regensburg University, Germany
  • Co-Chair: Valentina Colcelli, Institute CNR_IFAC, Italy
  • Mentor: Rosita Kammler, International Breast Cancer Study Group (IBCSG)European Thoracic Oncology Platform (ETOP), Switzerland 
 

GROUP's ONLINE COMMUNITY


QUALITY MANAGEMENT WG

Quality of biosamples, data and biobanking processes is critical for excellence of biomedical research. It determines the future success of repeatability and reproducibility of the scientific experiments resulting in the creation and development of new biomedical outcomes. The work group will be focused on developing and improving the knowledge regarding quality aspects based on best practices and dedicated standards for biobanks. The key points will be concentrated on biobanks accreditation and certification processes to ensure the conformity with the highest quality and safety standards.  

  • Co-Chair: Dr. Ronny Baber, Leipzig Medical Biobank - University Leipzig, Germany
  • Co-Chair: Agnieszka Matera-Witkiewicz, Head of Wroclaw Medical University Biobank , Poland

 

GROUP's ONLINE COMMUNITY

SUSTAINABILITY TASK FORCE

This task force (TF) addresses sustainability for biobanks on all levels with the aim for financial and infrastructural sustainability. We work on concepts on how to reach sustainability for individual biobanks while addressing this substantial topic overall with authority bodies, funding agencies and politicians nationally and on the EU level. For more information and activities, please visit this TF’s domain or contact the TF chair. 

  • Chair: Rosita Kammler , International Breast Cancer Study Group (IBCSG)European Thoracic Oncology Platform (ETOP)Switzerland

GROUP's ONLINE COMMUNITY